BMY Annual Total Debt
$41.46 B
+$747.00 M+1.83%
31 December 2023
Summary:
As of January 22, 2025, BMY annual total debt is $41.46 billion, with the most recent change of +$747.00 million (+1.83%) on December 31, 2023. During the last 3 years, it has fallen by -$10.21 billion (-19.76%). BMY annual total debt is now -19.76% below its all-time high of $51.67 billion, reached on December 31, 2020.BMY Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY Quarterly Total Debt
$51.40 B
-$2.60 B-4.82%
30 September 2024
Summary:
As of January 22, 2025, BMY quarterly total debt is $51.40 billion, with the most recent change of -$2.60 billion (-4.82%) on September 30, 2024. Over the past year, it has increased by +$9.94 billion (+23.96%). BMY quarterly total debt is now -10.47% below its all-time high of $57.41 billion, reached on March 31, 2024.BMY Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.8% | +24.0% |
| 3 y3 years | -19.8% | +24.0% |
| 5 y5 years | +464.2% | +24.0% |
BMY Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.1% | +1.8% | -10.5% | +31.2% |
| 5 y | 5-year | -19.8% | +1.8% | -10.5% | +31.2% |
| alltime | all time | -19.8% | +7904.6% | -10.5% |
Bristol-Myers Squibb Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $51.40 B(-4.8%) |
| June 2024 | - | $54.00 B(-5.9%) |
| Mar 2024 | - | $57.41 B(+38.5%) |
| Dec 2023 | $41.46 B(+1.8%) | $41.46 B(+5.6%) |
| Sept 2023 | - | $39.27 B(+0.2%) |
| June 2023 | - | $39.19 B(-0.5%) |
| Mar 2023 | - | $39.37 B(-3.3%) |
| Dec 2022 | $40.72 B(-10.7%) | $40.72 B(+1.5%) |
| Sept 2022 | - | $40.11 B(-6.8%) |
| June 2022 | - | $43.04 B(-6.4%) |
| Mar 2022 | - | $45.99 B(+0.9%) |
| Dec 2021 | $45.60 B(-11.8%) | $45.60 B(-0.5%) |
| Sept 2021 | - | $45.84 B(-1.0%) |
| June 2021 | - | $46.29 B(-2.1%) |
| Mar 2021 | - | $47.27 B(-8.5%) |
| Dec 2020 | $51.67 B(+8.7%) | $51.67 B(+12.8%) |
| Sept 2020 | - | $45.81 B(-3.6%) |
| June 2020 | - | $47.51 B(-0.0%) |
| Mar 2020 | - | $47.53 B(-0.0%) |
| Dec 2019 | $47.54 B(+546.9%) | $47.54 B(+90.0%) |
| Sept 2019 | - | $25.02 B(-0.1%) |
| June 2019 | - | $25.05 B(+313.6%) |
| Mar 2019 | - | $6.06 B(-17.6%) |
| Dec 2018 | $7.35 B(-7.7%) | $7.35 B(+0.6%) |
| Sept 2018 | - | $7.31 B(-1.1%) |
| June 2018 | - | $7.39 B(-4.1%) |
| Mar 2018 | - | $7.70 B(-3.3%) |
| Dec 2017 | $7.96 B(+18.7%) | $7.96 B(-5.7%) |
| Sept 2017 | - | $8.44 B(+2.8%) |
| June 2017 | - | $8.22 B(-2.6%) |
| Mar 2017 | - | $8.43 B(+25.7%) |
| Dec 2016 | $6.71 B(+0.3%) | $6.71 B(-1.7%) |
| Sept 2016 | - | $6.83 B(+1.3%) |
| June 2016 | - | $6.74 B(+0.6%) |
| Mar 2016 | - | $6.70 B(+0.1%) |
| Dec 2015 | $6.69 B(-14.6%) | $6.69 B(-8.0%) |
| Sept 2015 | - | $7.27 B(-1.3%) |
| June 2015 | - | $7.37 B(-1.2%) |
| Mar 2015 | - | $7.46 B(-4.8%) |
| Dec 2014 | $7.83 B(-6.1%) | $7.83 B(+2.1%) |
| Sept 2014 | - | $7.67 B(-0.9%) |
| June 2014 | - | $7.74 B(+1.2%) |
| Mar 2014 | - | $7.65 B(-8.3%) |
| Dec 2013 | $8.34 B(+12.8%) | $8.34 B(+15.6%) |
| Sept 2013 | - | $7.21 B(+0.1%) |
| June 2013 | - | $7.21 B(-8.7%) |
| Mar 2013 | - | $7.89 B(+6.8%) |
| Dec 2012 | $7.39 B(+34.7%) | $7.39 B(+0.5%) |
| Sept 2012 | - | $7.36 B(+35.2%) |
| June 2012 | - | $5.45 B(+0.6%) |
| Mar 2012 | - | $5.42 B(-1.4%) |
| Dec 2011 | $5.49 B(+0.8%) | $5.49 B(-2.3%) |
| Sept 2011 | - | $5.62 B(+1.8%) |
| June 2011 | - | $5.52 B(+2.0%) |
| Mar 2011 | - | $5.41 B(-0.6%) |
| Dec 2010 | $5.45 B(-14.4%) | $5.45 B(>+9900.0%) |
| Sept 2010 | - | $0.00(-100.0%) |
| June 2010 | - | $6.54 B(+4.0%) |
| Mar 2010 | - | $6.29 B(-1.1%) |
| Dec 2009 | $6.36 B(-5.6%) | $6.36 B(-3.5%) |
| Sept 2009 | - | $6.59 B(+3.7%) |
| June 2009 | - | $6.36 B(-4.3%) |
| Mar 2009 | - | $6.65 B(-1.4%) |
| Dec 2008 | $6.74 B(+7.4%) | $6.74 B(+7.7%) |
| Sept 2008 | - | $6.25 B(-20.0%) |
| June 2008 | - | $7.82 B(+21.4%) |
| Mar 2008 | - | $6.44 B(+2.7%) |
| Dec 2007 | $6.27 B(-15.6%) | $6.27 B(+2.4%) |
| Sept 2007 | - | $6.13 B(-15.3%) |
| June 2007 | - | $7.23 B(-1.9%) |
| Mar 2007 | - | $7.37 B(-0.8%) |
| Dec 2006 | $7.43 B(-13.5%) | $7.43 B(-12.2%) |
| Sept 2006 | - | $8.47 B(+0.5%) |
| June 2006 | - | $8.43 B(-1.0%) |
| Mar 2006 | - | $8.51 B(-1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2005 | $8.60 B(-16.9%) | $8.60 B(+39.3%) |
| Sept 2005 | - | $6.17 B(-2.0%) |
| June 2005 | - | $6.30 B(-26.5%) |
| Mar 2005 | - | $8.57 B(-17.2%) |
| Dec 2004 | $10.35 B(+18.2%) | $10.35 B(+1.5%) |
| Sept 2004 | - | $10.19 B(+8.6%) |
| June 2004 | - | $9.38 B(-0.3%) |
| Mar 2004 | - | $9.41 B(+7.5%) |
| Dec 2003 | $8.75 B(+14.6%) | $8.75 B(+0.5%) |
| Sept 2003 | - | $8.71 B(+4.6%) |
| June 2003 | - | $8.32 B(-3.4%) |
| Mar 2003 | - | $8.61 B(+12.7%) |
| Dec 2002 | $7.64 B(+19.2%) | $7.64 B(+9.1%) |
| Sept 2002 | - | $7.00 B(+1.1%) |
| June 2002 | - | $6.92 B(+6.9%) |
| Mar 2002 | - | $6.48 B(+1.0%) |
| Dec 2001 | $6.41 B(+328.0%) | $6.41 B(-19.8%) |
| Sept 2001 | - | $7.99 B(+446.0%) |
| June 2001 | - | $1.46 B(-2.2%) |
| Mar 2001 | - | $1.50 B(-0.1%) |
| Dec 2000 | $1.50 B(-15.6%) | $1.50 B(+0.1%) |
| Sept 2000 | - | $1.50 B(-5.8%) |
| June 2000 | - | $1.59 B(-6.5%) |
| Mar 2000 | - | $1.70 B(-4.3%) |
| Dec 1999 | $1.77 B(-3.9%) | $1.77 B(-3.7%) |
| Sept 1999 | - | $1.84 B(-1.6%) |
| June 1999 | - | $1.87 B(-1.6%) |
| Mar 1999 | - | $1.90 B(+3.1%) |
| Dec 1998 | $1.85 B(+1.3%) | $1.85 B(+1.5%) |
| Sept 1998 | - | $1.82 B(+1.6%) |
| June 1998 | - | $1.79 B(-7.3%) |
| Mar 1998 | - | $1.93 B(+5.9%) |
| Dec 1997 | $1.82 B(+23.2%) | $1.82 B(+0.9%) |
| Sept 1997 | - | $1.80 B(+13.3%) |
| June 1997 | - | $1.59 B(+2.6%) |
| Mar 1997 | - | $1.55 B(+4.9%) |
| Dec 1996 | $1.48 B(+22.2%) | $1.48 B(+27.9%) |
| Sept 1996 | - | $1.16 B(+8.2%) |
| June 1996 | - | $1.07 B(-7.3%) |
| Mar 1996 | - | $1.15 B(-4.8%) |
| Dec 1995 | $1.21 B(-11.6%) | $1.21 B(-9.1%) |
| Sept 1995 | - | $1.33 B(-11.9%) |
| June 1995 | - | $1.51 B(+3.4%) |
| Mar 1995 | - | $1.46 B(+6.7%) |
| Dec 1994 | $1.37 B(+79.0%) | $1.37 B(-1.8%) |
| Sept 1994 | - | $1.39 B(+62.7%) |
| June 1994 | - | $857.00 M(+2.3%) |
| Mar 1994 | - | $838.00 M(+9.5%) |
| Dec 1993 | $765.00 M(+38.8%) | $765.00 M(+26.7%) |
| Sept 1993 | - | $604.00 M(-29.6%) |
| June 1993 | - | $858.00 M(+74.7%) |
| Mar 1993 | - | $491.00 M(-10.9%) |
| Dec 1992 | $551.00 M(-19.9%) | $551.00 M(+1.1%) |
| Sept 1992 | - | $545.00 M(+2.6%) |
| June 1992 | - | $531.00 M(-8.6%) |
| Mar 1992 | - | $581.00 M(-15.6%) |
| Dec 1991 | $688.00 M(+9.6%) | $688.00 M(+15.2%) |
| Sept 1991 | - | $597.00 M(+4.7%) |
| June 1991 | - | $570.00 M(+4.2%) |
| Mar 1991 | - | $547.00 M(-12.9%) |
| Dec 1990 | $628.00 M(+21.2%) | $628.00 M(+10.0%) |
| Sept 1990 | - | $571.00 M(+3.6%) |
| June 1990 | - | $551.00 M(+7.2%) |
| Mar 1990 | - | $514.00 M(-0.8%) |
| Dec 1989 | $518.00 M(-46.2%) | $518.00 M(>+9900.0%) |
| Sept 1989 | - | $0.00(0.0%) |
| June 1989 | - | $0.00(0.0%) |
| Mar 1989 | - | $0.00(-100.0%) |
| Dec 1988 | $963.00 M(+38.8%) | $963.00 M(>+9900.0%) |
| Sept 1988 | - | $0.00(0.0%) |
| June 1988 | - | $0.00(0.0%) |
| Mar 1988 | - | $0.00(-100.0%) |
| Dec 1987 | $694.00 M | $694.00 M(>+9900.0%) |
| Sept 1987 | - | $0.00(0.0%) |
| June 1987 | - | $0.00(0.0%) |
| Mar 1987 | - | $0.00 |
FAQ
- What is Bristol-Myers Squibb annual total debt?
- What is the all time high annual total debt for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual total debt year-on-year change?
- What is Bristol-Myers Squibb quarterly total debt?
- What is the all time high quarterly total debt for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly total debt year-on-year change?
What is Bristol-Myers Squibb annual total debt?
The current annual total debt of BMY is $41.46 B
What is the all time high annual total debt for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual total debt is $51.67 B
What is Bristol-Myers Squibb annual total debt year-on-year change?
Over the past year, BMY annual total debt has changed by +$747.00 M (+1.83%)
What is Bristol-Myers Squibb quarterly total debt?
The current quarterly total debt of BMY is $51.40 B
What is the all time high quarterly total debt for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly total debt is $57.41 B
What is Bristol-Myers Squibb quarterly total debt year-on-year change?
Over the past year, BMY quarterly total debt has changed by +$9.94 B (+23.96%)